ALOE FEROX LEAF

ALOE FEROX LEAF was reported 181 times

ALOE FEROX LEAF is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 DIFFUSE IDIOPATHIC PULMONARY NEUROENDOCRINE CELL HYPERPLASIA 1 0.1667
1 SKIN PROCEDURAL COMPLICATION 1 0.0588
2 VULVOVAGINAL HUMAN PAPILLOMA VIRUS INFECTION 1 0.0323
3 TAKAYASU'S ARTERITIS 1 0.0294
4 TONSILLAR CYST 1 0.0244
5 PROGESTERONE ABNORMAL 1 0.0222
6 NEURECTOMY 1 0.0154
7 REFLUX NEPHROPATHY 1 0.0152
8 NEUTROPHILIC PANNICULITIS 1 0.0139
9 EAR, NOSE AND THROAT INFECTION 1 0.0122
10 ENVIRONMENTAL EXPOSURE 2 0.0084
11 HERPES ZOSTER INFECTION NEUROLOGICAL 1 0.0063
12 AMINO ACID LEVEL DECREASED 2 0.0059
13 BLOOD OESTROGEN ABNORMAL 1 0.0058
14 DIAPHRAGMALGIA 2 0.0058
15 GLOSSOPTOSIS 1 0.0046
16 CARDIAC SARCOIDOSIS 1 0.0043
17 ANORECTAL OPERATION 1 0.0042
18 SOLAR DERMATITIS 1 0.0037
19 BURKHOLDERIA CEPACIA COMPLEX INFECTION 1 0.0035
20 TONSILLAR INFLAMMATION 1 0.0031
21 ACQUIRED OESOPHAGEAL WEB 1 0.0029
22 OESOPHAGEAL MOTILITY DISORDER 1 0.0028
23 LID SULCUS DEEPENED 1 0.0027
24 PENILE ERYTHEMA 1 0.0027
25 PORPHYRIA 1 0.0026
26 INFUSION SITE DISCOLOURATION 2 0.0023
27 BANKRUPTCY 1 0.0022
28 ALLERGY TO PLANTS 1 0.0022
29 PERIORBITAL CELLULITIS 1 0.0019
30 GENITAL DISCOMFORT 1 0.0018
31 URETHRAL PAIN 1 0.0017
32 VITAMIN D INCREASED 1 0.0016
33 BLADDER IRRITATION 1 0.0016
34 INFUSION SITE IRRITATION 2 0.0016
35 INFUSION SITE RASH 2 0.0015
36 FLUID IMBALANCE 1 0.0014
37 INFECTION IN AN IMMUNOCOMPROMISED HOST 1 0.0014
38 IMMUNISATION REACTION 1 0.0014
39 EYELID FUNCTION DISORDER 1 0.0013
40 BARRETT'S OESOPHAGUS 1 0.0012
41 HEAT EXHAUSTION 1 0.0012
42 PENILE HAEMORRHAGE 1 0.0012
43 MYCOSIS FUNGOIDES 1 0.0012
44 ERYTHRODERMIC PSORIASIS 1 0.0012
45 SPLEEN DISORDER 2 0.0012
46 CRANIOFACIAL FRACTURE 1 0.0012
47 INFUSION SITE DISCHARGE 2 0.0011
48 SALIVA ALTERED 1 0.0011
49 HAEMOCHROMATOSIS 1 0.0011
50 CONSCIOUSNESS FLUCTUATING 1 0.0010
51 INFUSION SITE BRUISING 2 0.0009
52 INFUSION SITE MASS 1 0.0009
53 LIGAMENT INJURY 1 0.0009
54 BLOOD IMMUNOGLOBULIN G INCREASED 1 0.0008
55 PENILE SWELLING 1 0.0008
56 POLYTRAUMATISM 1 0.0007
57 BLOOD SODIUM INCREASED 2 0.0007
58 EFFUSION 1 0.0007
59 ABSCESS ORAL 1 0.0007
60 GENERALISED ANXIETY DISORDER 1 0.0007
61 AGE-RELATED MACULAR DEGENERATION 1 0.0007
62 INFUSION SITE SWELLING 4 0.0006
63 INFUSION SITE PRURITUS 2 0.0006
64 CYSTITIS INTERSTITIAL 1 0.0006
65 LOOSE TOOTH 2 0.0006
66 LEUKOCYTOCLASTIC VASCULITIS 1 0.0006
67 EROSIVE OESOPHAGITIS 1 0.0006
68 FEMALE GENITAL TRACT FISTULA 1 0.0006
69 MILIARIA 1 0.0006
70 TREATMENT DELAYED 1 0.0006
71 INFUSION SITE PAIN 7 0.0005
72 LYMPH NODE PAIN 1 0.0005
73 BLADDER SPASM 1 0.0005
74 PARANASAL SINUS DISCOMFORT 2 0.0005
75 MULTIPLE ALLERGIES 4 0.0005
76 INFUSION SITE EXTRAVASATION 3 0.0005
77 ORAL PRURITUS 1 0.0004
78 BREAKTHROUGH PAIN 1 0.0004
79 FLAT AFFECT 1 0.0004
80 RESPIRATORY TRACT INFECTION VIRAL 1 0.0004
81 INGROWING NAIL 1 0.0004
82 APPLICATION SITE BURN 2 0.0004
83 INCREASED BRONCHIAL SECRETION 1 0.0004
84 RETINAL DISORDER 1 0.0004
85 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 1 0.0004
86 BLOOD POTASSIUM ABNORMAL 1 0.0004
87 GINGIVITIS 2 0.0004
88 RHINALGIA 1 0.0004
89 SEASONAL ALLERGY 5 0.0004
90 OESOPHAGEAL STENOSIS 1 0.0004
91 PARAPLEGIA 1 0.0003
92 FINE MOTOR SKILL DYSFUNCTION 1 0.0003
93 DYSPNOEA AT REST 1 0.0003
94 ATYPICAL PNEUMONIA 1 0.0003
95 ACNE CYSTIC 1 0.0003
96 KERATITIS 1 0.0003
97 NASAL DRYNESS 2 0.0003
98 DRUG EFFECT INCREASED 1 0.0003
99 STUPOR 1 0.0003
100 INFUSION SITE HAEMORRHAGE 1 0.0003
101 NEAR DEATH EXPERIENCE 1 0.0003
102 TOOTH ABSCESS 3 0.0003
103 SUDDEN CARDIAC DEATH 1 0.0003
104 GRANULOMA 1 0.0003
105 TENDERNESS 3 0.0003
106 THERMAL BURN 2 0.0003
107 DEVICE KINK 1 0.0003
108 ASTHMATIC CRISIS 1 0.0003
109 FREEZING PHENOMENON 1 0.0003
110 CHRONIC SINUSITIS 1 0.0003
111 DERMATITIS CONTACT 3 0.0003
112 PARANASAL SINUS HYPERSECRETION 1 0.0003
113 GASTRIC INFECTION 1 0.0003
114 REHABILITATION THERAPY 1 0.0003
115 MUSCLE RUPTURE 1 0.0003
116 CANDIDIASIS 1 0.0002
117 FUNGAL SKIN INFECTION 1 0.0002
118 MUSCLE DISORDER 2 0.0002
119 PERIPHERAL VENOUS DISEASE 1 0.0002
120 INFUSION SITE ERYTHEMA 2 0.0002
121 LIP OEDEMA 1 0.0002
122 BLOOD MAGNESIUM DECREASED 2 0.0002
123 HORDEOLUM 1 0.0002
124 OCULAR ICTERUS 1 0.0002
125 SKIN SWELLING 2 0.0002
126 CHAPPED LIPS 1 0.0002
127 TONGUE DISCOLOURATION 1 0.0002
128 VULVOVAGINAL DISCOMFORT 1 0.0002
129 SNEEZING 5 0.0002
130 MENINGITIS ASEPTIC 1 0.0002
131 VASCULAR DEVICE INFECTION 1 0.0002
132 ABDOMINAL HERNIA 1 0.0002
133 THERAPEUTIC PRODUCT EFFECT DELAYED 1 0.0002
134 ARTHRITIS INFECTIVE 1 0.0002
135 ROSACEA 1 0.0002
136 RECALLED PRODUCT ADMINISTERED 2 0.0002
137 HAEMORRHOIDAL HAEMORRHAGE 1 0.0002
138 FOOT OPERATION 1 0.0002
139 PROTEIN URINE PRESENT 1 0.0002
140 INSURANCE ISSUE 3 0.0002
141 SERUM FERRITIN INCREASED 1 0.0002
142 ANAL FISSURE 1 0.0002
143 NONSPECIFIC REACTION 1 0.0002
144 PHOTOSENSITIVITY REACTION 3 0.0002
145 TOOTH FRACTURE 2 0.0002
146 HYPERKERATOSIS 1 0.0002
147 PRODUCT PHYSICAL CONSISTENCY ISSUE 1 0.0002
148 OBSTRUCTIVE AIRWAYS DISORDER 2 0.0002
149 OCULAR DISCOMFORT 2 0.0002
150 EYE INFECTION 2 0.0002
151 PERIORBITAL SWELLING 1 0.0002
152 MOUTH SWELLING 1 0.0002
153 SOCIAL AVOIDANT BEHAVIOUR 1 0.0002
154 BLOOD IRON DECREASED 2 0.0002
155 SQUAMOUS CELL CARCINOMA OF SKIN 1 0.0002
156 INJECTION SITE VESICLES 1 0.0002
157 VULVOVAGINAL BURNING SENSATION 1 0.0002
158 SCOLIOSIS 1 0.0002
159 TOOTH EXTRACTION 2 0.0002
160 SECRETION DISCHARGE 2 0.0002
161 INJECTION SITE IRRITATION 2 0.0002
162 HERPES SIMPLEX 1 0.0002
163 RESPIRATORY TRACT INFECTION 4 0.0002
164 NODULE 2 0.0002
165 WALKING AID USER 1 0.0002
166 EAR INFECTION 4 0.0002
167 TERMINAL STATE 1 0.0001
168 POST-TRAUMATIC STRESS DISORDER 1 0.0001
169 PAIN OF SKIN 4 0.0001
170 BRONCHIECTASIS 1 0.0001
171 POSTOPERATIVE WOUND INFECTION 1 0.0001
172 SINUS CONGESTION 2 0.0001
173 ECCHYMOSIS 1 0.0001
174 DROOLING 1 0.0001
175 PRODUCT SUPPLY ISSUE 1 0.0001
176 PULMONARY ARTERIAL HYPERTENSION 2 0.0001
177 FAECES SOFT 1 0.0001
178 LIQUID PRODUCT PHYSICAL ISSUE 1 0.0001
179 INTENTIONAL UNDERDOSE 1 0.0001
180 PSYCHIATRIC SYMPTOM 1 0.0001
181 TOOTH DISORDER 3 0.0001
182 EYE SWELLING 5 0.0001
183 ORAL PAIN 3 0.0001
184 BOWEL MOVEMENT IRREGULARITY 1 0.0001
185 DEVICE PHYSICAL PROPERTY ISSUE 1 0.0001
186 INTERCEPTED PRODUCT ADMINISTRATION ERROR 1 0.0001
187 UPPER RESPIRATORY TRACT INFECTION 6 0.0001
188 THYROID DISORDER 2 0.0001
189 TENDONITIS 2 0.0001
190 CONCUSSION 1 0.0001
191 NICOTINE DEPENDENCE 1 0.0001
192 RENAL CYST 1 0.0001
193 PRODUCTIVE COUGH 6 0.0001
194 GINGIVAL PAIN 1 0.0001
195 ATRIAL FLUTTER 1 0.0001
196 BLOOD PRESSURE FLUCTUATION 3 0.0001
197 MYASTHENIA GRAVIS 1 0.0001
198 POST PROCEDURAL INFECTION 1 0.0001
199 UPPER-AIRWAY COUGH SYNDROME 1 0.0001
200 EMBOLISM 1 0.0001
201 FUNGAL INFECTION 4 0.0001
202 SENSATION OF FOREIGN BODY 1 0.0001
203 INADEQUATE ANALGESIA 1 0.0001
204 SINUSITIS 12 0.0001
205 VITAMIN D DECREASED 1 0.0001
206 UNRESPONSIVE TO STIMULI 3 0.0001
207 PYELONEPHRITIS 1 0.0001
208 RESPIRATORY SYNCYTIAL VIRUS INFECTION 1 0.0001
209 URINE OUTPUT DECREASED 1 0.0001
210 BLOOD CALCIUM INCREASED 1 0.0001
211 GRIP STRENGTH DECREASED 1 0.0001
212 FACIAL PAIN 1 0.0001
213 MENSTRUATION IRREGULAR 3 0.0001
214 GASTROINTESTINAL INFECTION 1 0.0001
215 GASTROENTERITIS VIRAL 2 0.0001
216 LIP DRY 1 0.0001
217 EXOSTOSIS 1 0.0001
218 RETINAL DETACHMENT 1 0.0001
219 NERVE COMPRESSION 1 0.0001
220 GRAND MAL CONVULSION 1 0.0001
221 PRODUCT DISTRIBUTION ISSUE 1 0.0001
222 PERSONALITY CHANGE 1 0.0001
223 DIARRHOEA HAEMORRHAGIC 1 0.0001
224 OCULAR HYPERAEMIA 5 0.0001
225 DIZZINESS POSTURAL 1 0.0001
226 NASAL CONGESTION 6 0.0001
227 VITREOUS FLOATERS 1 0.0001
228 THERAPY CHANGE 1 0.0001
229 LIGAMENT SPRAIN 1 0.0001
230 SINUS DISORDER 2 0.0001
231 BLADDER DISORDER 1 0.0001
232 SALIVARY HYPERSECRETION 1 0.0001
233 FULL BLOOD COUNT DECREASED 2 0.0001
234 INITIAL INSOMNIA 1 0.0001
235 HELICOBACTER INFECTION 1 0.0001
236 ROAD TRAFFIC ACCIDENT 4 0.0001
237 WEIGHT FLUCTUATION 1 0.0001
238 PRODUCT ODOUR ABNORMAL 1 0.0001
239 DERMATITIS 2 0.0001
240 JOINT DISLOCATION 1 0.0001
241 SUDDEN DEATH 1 0.0001
242 IMPAIRED WORK ABILITY 2 0.0001
243 HEREDITARY ANGIOEDEMA 1 0.0001
244 DECREASED ACTIVITY 1 0.0001
245 SKIN LACERATION 1 0.0001
246 PULMONARY THROMBOSIS 1 0.0001
247 DENTAL CARIES 1 0.0001
248 RED BLOOD CELL SEDIMENTATION RATE INCREASED 1 0.0001
249 SKIN DISORDER 3 0.0001
250 NERVE INJURY 1 0.0001
251 MALNUTRITION 1 0.0001
252 SKIN INFECTION 1 0.0001
253 BLOOD CALCIUM DECREASED 1 0.0001
254 MYOCARDIAL ISCHAEMIA 1 0.0001
255 PRODUCT AVAILABILITY ISSUE 2 0.0001
256 SCAB 1 0.0001
257 COVID-19 PNEUMONIA 1 0.0001
258 LOCALISED INFECTION 2 0.0001
259 DYSURIA 3 0.0001
260 CYST 1 0.0001
261 ROTATOR CUFF SYNDROME 1 0.0001
262 SWELLING FACE 5 0.0001
263 INCORRECT PRODUCT STORAGE 1 0.0001
264 IMMUNE SYSTEM DISORDER 1 0.0001
265 TOOTH INFECTION 1 0.0001
266 LIMB INJURY 2 0.0001
267 SKIN LESION 2 0.0001
268 DIVERTICULITIS 2 0.0001
269 MENTAL STATUS CHANGES 2 0.0001
270 FEELING COLD 2 0.0001
271 COORDINATION ABNORMAL 1 0.0001
272 URTICARIA 12 0.0001
273 NECK PAIN 4 0.0001
274 WOUND 2 0.0001
275 MASS 1 0.0001
276 DEVICE OCCLUSION 1 0.0001
277 HYPONATRAEMIA 4 0.0001
278 EYE PAIN 4 0.0001
279 PRODUCT DOSE OMISSION IN ERROR 2 0.0001
280 MULTIPLE ORGAN DYSFUNCTION SYNDROME 2 0.0001
281 PARALYSIS 1 0.0001
282 SKIN BURNING SENSATION 5 0.0001
283 IMPAIRED QUALITY OF LIFE 1 0.0001
284 PARAESTHESIA ORAL 1 0.0001
285 ANOSMIA 1 0.0001
286 HYPERTHYROIDISM 1 0.0001
287 COMPLICATION ASSOCIATED WITH DEVICE 1 0.0001
288 APATHY 1 0.0001
289 ASCITES 2 0.0001
290 DRUG EFFECT LESS THAN EXPECTED 1 0.0001
291 PULMONARY MASS 1 0.0001
292 ECONOMIC PROBLEM 1 0.0001
293 BLOOD COUNT ABNORMAL 1 0.0001
294 TOXIC EPIDERMAL NECROLYSIS 1 0.0001
295 SKIN IRRITATION 3 0.0001
296 BASAL CELL CARCINOMA 1 0.0001
297 BRAIN FOG 1 0.0001
298 PRODUCT USE COMPLAINT 1 0.0001
299 BLOOD LACTATE DEHYDROGENASE INCREASED 1 0.0001
300 PNEUMOTHORAX 1 0.0001
301 RESPIRATORY TRACT CONGESTION 1 0.0001
302 ULCER 1 0.0001
303 SCIATICA 1 0.0001
304 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 3 0.0001
305 MOVEMENT DISORDER 2 0.0001
306 STAPHYLOCOCCAL INFECTION 2 0.0001
307 EXPIRED PRODUCT ADMINISTERED 2 0.0001
308 VIRAL INFECTION 2 0.0001
309 NASOPHARYNGITIS 11 0.0001
310 EYE PRURITUS 2 0.0001
311 FLUID RETENTION 3 0.0001
312 SCAR 1 0.0001
313 ERYTHEMA 12 0.0001
314 ILLNESS 6 0.0001
315 DELIRIUM 2 0.0001
316 SPEECH DISORDER 3 0.0001
317 COLD SWEAT 1 0.0001
318 BLOOD TRIGLYCERIDES INCREASED 1 0.0001
319 GOUT 1 0.0001
320 RASH PRURITIC 3 0.0001
321 INFECTION 8 0.0001
322 TOOTHACHE 1 0.0001
323 C-REACTIVE PROTEIN INCREASED 2 0.0001
324 BONE DISORDER 1 0.0001
325 PANIC ATTACK 2 0.0001
326 HAEMATOCHEZIA 3 0.0001
327 DYSGEUSIA 4 0.0001
328 HEPATIC STEATOSIS 1 0.0001
329 MIDDLE INSOMNIA 1 0.0001
330 OXYGEN SATURATION DECREASED 3 0.0001
331 TUBULOINTERSTITIAL NEPHRITIS 1 0.0001
332 BLOOD SODIUM DECREASED 1 0.0001
333 HYPOCALCAEMIA 1 0.0001
334 SLEEP APNOEA SYNDROME 1 0.0001
335 GLAUCOMA 1 0.0001
336 ERUCTATION 1 0.0001
337 PRESCRIBED OVERDOSE 1 0.0001
338 EAR PAIN 1 0.0001
339 DYSPHONIA 3 0.0001
340 HAEMORRHOIDS 1 0.0001
341 CHOKING 1 0.0001
342 ORAL HERPES 1 0.0001
343 KIDNEY INFECTION 1 0.0001
344 BLOOD PRESSURE ABNORMAL 1 0.0001
345 UPPER LIMB FRACTURE 1 0.0001
346 SPINAL FRACTURE 1 0.0000
347 PRODUCT PHYSICAL ISSUE 1 0.0000
348 STOMATITIS 3 0.0000
349 FEEDING DISORDER 1 0.0000
350 TASTE DISORDER 1 0.0000
351 INJECTION SITE WARMTH 1 0.0000
352 TOOTH LOSS 1 0.0000
353 WITHDRAWAL SYNDROME 2 0.0000
354 EATING DISORDER 1 0.0000
355 RETCHING 1 0.0000
356 JOINT INJURY 1 0.0000
357 RHINORRHOEA 3 0.0000
358 DEVICE DISLOCATION 2 0.0000
359 SEPTIC SHOCK 2 0.0000
360 CLOSTRIDIUM DIFFICILE INFECTION 1 0.0000
361 INFUSION RELATED REACTION 3 0.0000
362 LIVER DISORDER 2 0.0000
363 STEVENS-JOHNSON SYNDROME 1 0.0000
364 RASH MACULO-PAPULAR 1 0.0000
365 GLOSSODYNIA 1 0.0000
366 ASTHMA 5 0.0000
367 APPLICATION SITE PRURITUS 1 0.0000
368 SKIN DISCOLOURATION 2 0.0000
369 MUSCLE TWITCHING 1 0.0000
370 MIGRAINE 4 0.0000
371 MOBILITY DECREASED 3 0.0000
372 BLOOD GLUCOSE DECREASED 2 0.0000
373 CONTUSION 4 0.0000
374 FIBROMYALGIA 1 0.0000
375 PRESYNCOPE 1 0.0000
376 URINARY TRACT INFECTION 7 0.0000
377 ENCEPHALOPATHY 1 0.0000
378 DYSPEPSIA 4 0.0000
379 EPISTAXIS 3 0.0000
380 AGEUSIA 1 0.0000
381 COVID-19 7 0.0000
382 HOT FLUSH 3 0.0000
383 ABDOMINAL PAIN LOWER 1 0.0000
384 HYPOPHAGIA 1 0.0000
385 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 1 0.0000
386 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 2 0.0000
387 SEDATION 1 0.0000
388 APPLICATION SITE ERYTHEMA 1 0.0000
389 JOINT STIFFNESS 1 0.0000
390 GASTROOESOPHAGEAL REFLUX DISEASE 3 0.0000
391 BLOOD BILIRUBIN INCREASED 1 0.0000
392 THROAT TIGHTNESS 1 0.0000
393 OEDEMA 2 0.0000
394 PALLOR 1 0.0000
395 PNEUMONITIS 1 0.0000
396 MOOD ALTERED 1 0.0000
397 RESPIRATORY DISTRESS 1 0.0000
398 PROCEDURAL PAIN 1 0.0000
399 ARTHROPATHY 2 0.0000
400 HAEMOPTYSIS 1 0.0000
401 DEMENTIA 1 0.0000
402 BLISTER 2 0.0000
403 SKIN EXFOLIATION 3 0.0000
404 INCORRECT DRUG ADMINISTRATION DURATION 1 0.0000
405 FLATULENCE 2 0.0000
406 HYPERSOMNIA 1 0.0000
407 BALANCE DISORDER 3 0.0000
408 NEEDLE ISSUE 1 0.0000
409 DYSSTASIA 1 0.0000
410 BONE PAIN 2 0.0000
411 CHILLS 4 0.0000
412 PSYCHOTIC DISORDER 1 0.0000
413 DEVICE ISSUE 3 0.0000
414 ADVERSE DRUG REACTION 3 0.0000
415 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 6 0.0000
416 LACRIMATION INCREASED 1 0.0000
417 VERTIGO 2 0.0000
418 EPILEPSY 1 0.0000
419 BLOOD PRESSURE INCREASED 5 0.0000
420 ACUTE KIDNEY INJURY 5 0.0000
421 FEELING HOT 2 0.0000
422 DRUG ADMINISTRATION ERROR 1 0.0000
423 OROPHARYNGEAL PAIN 3 0.0000
424 CHEST PAIN 6 0.0000
425 LIMB DISCOMFORT 1 0.0000
426 WEIGHT DECREASED 9 0.0000
427 RASH 14 0.0000
428 COUGH 9 0.0000
429 DYSPNOEA 18 0.0000
430 CYSTITIS 1 0.0000
431 MOOD SWINGS 1 0.0000
432 ARTHRALGIA 13 0.0000
433 LOSS OF CONSCIOUSNESS 4 0.0000
434 PRODUCT DOSE OMISSION 2 0.0000
435 EYE DISORDER 1 0.0000
436 DEVICE DIFFICULT TO USE 2 0.0000
437 THERAPEUTIC RESPONSE SHORTENED 1 0.0000
438 VISUAL ACUITY REDUCED 1 0.0000
439 BLOOD PRESSURE DECREASED 2 0.0000
440 URINARY RETENTION 1 0.0000
441 TRANSIENT ISCHAEMIC ATTACK 1 0.0000
442 CHEST DISCOMFORT 3 0.0000
443 ABDOMINAL PAIN UPPER 6 0.0000
444 GASTRIC DISORDER 1 0.0000
445 NIGHTMARE 1 0.0000
446 ABDOMINAL DISTENSION 3 0.0000
447 HAEMORRHAGE 3 0.0000
448 BURNING SENSATION 2 0.0000
449 HEART RATE DECREASED 1 0.0000
450 LYMPHADENOPATHY 1 0.0000
451 SYSTEMIC LUPUS ERYTHEMATOSUS 1 0.0000
452 THERAPY INTERRUPTED 2 0.0000
453 PNEUMONIA 9 0.0000
454 CRYING 1 0.0000
455 MUSCLE SPASMS 5 0.0000
456 AGITATION 2 0.0000
457 PRODUCT DOSE OMISSION ISSUE 8 0.0000
458 PAIN IN EXTREMITY 8 0.0000
459 HEADACHE 17 0.0000
460 INJECTION SITE MASS 1 0.0000
461 BRONCHITIS 2 0.0000
462 PRODUCT USE ISSUE 5 0.0000
463 DYSPNOEA EXERTIONAL 1 0.0000
464 INTESTINAL OBSTRUCTION 1 0.0000
465 CHRONIC KIDNEY DISEASE 2 0.0000
466 BACK PAIN 6 0.0000
467 PALPITATIONS 3 0.0000
468 ARTHRITIS 2 0.0000
469 DEPRESSED LEVEL OF CONSCIOUSNESS 1 0.0000
470 ABNORMAL BEHAVIOUR 1 0.0000
471 FEELING ABNORMAL 6 0.0000
472 CARDIAC FAILURE 2 0.0000
473 DRY MOUTH 2 0.0000
474 OEDEMA PERIPHERAL 3 0.0000
475 PAIN 15 0.0000
476 OSTEOPOROSIS 1 0.0000
477 CARDIAC ARREST 2 0.0000
478 INJECTION SITE ERYTHEMA 3 0.0000
479 TREMOR 4 0.0000
480 ASTHENIA 9 0.0000
481 VOMITING 11 0.0000
482 FATIGUE 18 0.0000
483 VAGINAL HAEMORRHAGE 1 0.0000
484 PRODUCT STORAGE ERROR 2 0.0000
485 INTENTIONAL PRODUCT MISUSE 2 0.0000
486 ANGIOEDEMA 1 0.0000
487 RENAL FAILURE 3 0.0000
488 DEHYDRATION 3 0.0000
489 DRY SKIN 3 0.0000
490 WEIGHT INCREASED 5 0.0000
491 GASTROINTESTINAL DISORDER 2 0.0000
492 LOWER RESPIRATORY TRACT INFECTION 1 0.0000
493 DEPRESSION 5 0.0000
494 MEMORY IMPAIRMENT 3 0.0000
495 NEPHROLITHIASIS 1 0.0000
496 DIARRHOEA 14 0.0000
497 BLOOD CHOLESTEROL INCREASED 1 0.0000
498 COGNITIVE DISORDER 1 0.0000
499 CARDIAC DISORDER 2 0.0000
500 SWELLING 2 0.0000
501 DYSPHAGIA 2 0.0000
502 RASH ERYTHEMATOUS 1 0.0000
503 PRURITUS 8 0.0000
504 INTERSTITIAL LUNG DISEASE 1 0.0000
505 LUNG DISORDER 1 0.0000
506 PRODUCT USE IN UNAPPROVED INDICATION 5 0.0000
507 DIZZINESS 10 0.0000
508 DRY EYE 1 0.0000
509 SYNCOPE 2 0.0000
510 FLUSHING 2 0.0000
511 INFLAMMATION 1 0.0000
512 ECZEMA 1 0.0000
513 DERMATITIS ATOPIC 1 0.0000
514 DEPRESSED MOOD 1 0.0000
515 HYPERTENSION 4 0.0000
516 ASPARTATE AMINOTRANSFERASE INCREASED 1 0.0000
517 PLATELET COUNT DECREASED 2 0.0000
518 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
519 ANAPHYLACTIC REACTION 1 0.0000
520 FALL 6 0.0000
521 MYALGIA 3 0.0000
522 MUSCULAR WEAKNESS 2 0.0000
523 ANXIETY 5 0.0000
524 INCORRECT DOSE ADMINISTERED 4 0.0000
525 CONVULSION 1 0.0000
526 LETHARGY 1 0.0000
527 PRODUCT SUBSTITUTION ISSUE 1 0.0000
528 PYREXIA 6 0.0000
529 SEIZURE 2 0.0000
530 MYOCARDIAL INFARCTION 3 0.0000
531 ABDOMINAL PAIN 4 0.0000
532 BLADDER CANCER 1 0.0000
533 WHEEZING 1 0.0000
534 CATARACT 1 0.0000
535 IRRITABILITY 1 0.0000
536 THERAPEUTIC RESPONSE DECREASED 1 0.0000
537 CONDITION AGGRAVATED 5 0.0000
538 PLEURAL EFFUSION 1 0.0000
539 DISCOMFORT 1 0.0000
540 ALANINE AMINOTRANSFERASE INCREASED 1 0.0000
541 BLOOD GLUCOSE INCREASED 3 0.0000
542 HYPERHIDROSIS 2 0.0000
543 AMNESIA 1 0.0000
544 BLOOD CREATININE INCREASED 1 0.0000
545 PSORIASIS 2 0.0000
546 NAUSEA 12 0.0000
547 INSOMNIA 4 0.0000
548 INJECTION SITE PRURITUS 1 0.0000
549 SOMNOLENCE 3 0.0000
550 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 3 0.0000
551 HEPATIC ENZYME INCREASED 1 0.0000
552 MULTIPLE SCLEROSIS RELAPSE 1 0.0000
553 VISION BLURRED 2 0.0000
554 SLEEP DISORDER 1 0.0000
555 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1 0.0000
556 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 1 0.0000
557 CONSTIPATION 3 0.0000
558 RESPIRATORY FAILURE 1 0.0000
559 MALAISE 6 0.0000
560 HALLUCINATION 1 0.0000
561 UNEVALUABLE EVENT 1 0.0000
562 DIABETES MELLITUS 1 0.0000
563 INJECTION SITE SWELLING 1 0.0000
564 PERIPHERAL SWELLING 2 0.0000
565 DECREASED APPETITE 3 0.0000
566 DRUG DOSE OMISSION BY DEVICE 1 0.0000
567 PARAESTHESIA 2 0.0000
568 INJECTION SITE BRUISING 1 0.0000
569 CARDIAC FAILURE CONGESTIVE 1 0.0000
570 CONFUSIONAL STATE 2 0.0000
571 INFLUENZA LIKE ILLNESS 1 0.0000
572 CEREBROVASCULAR ACCIDENT 2 0.0000
573 INTENTIONAL PRODUCT USE ISSUE 1 0.0000
574 MUSCULOSKELETAL STIFFNESS 1 0.0000
575 TACHYCARDIA 1 0.0000
576 ANAEMIA 2 0.0000
577 GAIT DISTURBANCE 2 0.0000
578 ATRIAL FIBRILLATION 1 0.0000
579 ALOPECIA 2 0.0000
580 HEART RATE INCREASED 1 0.0000
581 HYPOTENSION 2 0.0000
582 HAEMOGLOBIN DECREASED 1 0.0000
583 ACCIDENTAL EXPOSURE TO PRODUCT 1 0.0000
584 WHITE BLOOD CELL COUNT DECREASED 1 0.0000
585 DRUG INEFFECTIVE 12 0.0000
586 INFLUENZA 1 0.0000
587 SEPSIS 1 0.0000
588 RHEUMATOID ARTHRITIS 1 0.0000
589 GENERAL PHYSICAL HEALTH DETERIORATION 1 0.0000
590 JOINT SWELLING 1 0.0000
591 EMOTIONAL DISTRESS 1 0.0000
592 VISUAL IMPAIRMENT 1 0.0000
593 PRODUCT QUALITY ISSUE 1 0.0000
594 NEUTROPENIA 1 0.0000
595 OFF LABEL USE 6 0.0000
596 HYPOAESTHESIA 1 0.0000
597 HOSPITALISATION 1 0.0000
598 DRUG INTERACTION 1 0.0000
599 DRUG DOSE OMISSION 1 0.0000
600 ABDOMINAL DISCOMFORT 1 0.0000
601 INJECTION SITE PAIN 1 0.0000